【会议】第二届国际新型抗体药物发展高峰论坛圆满成功
2019年5月18-19日，第二届国际新型抗体药物发展高峰论坛在深圳坪山区格兰云天酒店圆满完成。此次论坛为期两天，以“聚焦新型抗体技术，助力创新药物研发”为主题，围绕全球新型抗体药物的开发策略、平台技术、生产工艺、临床应用以及市场趋势等问题展开对话。
图1 会议开幕式。
南模生物受邀参加该会议，公司高级产品经理赵柏淞博士并在大会上做了主题为“ applications of humanized mouse models in immuno-oncology studies ”的报告，介绍了以重度免疫缺陷鼠和免疫系统人源化小鼠为代表的一系列相关产品，并与肿瘤免疫治疗领域内的专家进行了广泛交流。
图2 报告现场。
你也可能感兴趣
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
